ESR1 and skin basal cell carcinoma: Low metastatic estrogen receptor positive (ER+) BCC became highly metastatic in the presence of BAd whereas both ER+ and estrogen receptor negative (ER−) BCC with intrinsically higher metastatic capacity were unaffected by BAd.